Abingworth LLP 13D and 13G filings for Verona Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-11 4:54 pm Purchase | 2022-04-29 | 13D | Verona Pharma plc VRNA | Abingworth LLP | 21,313,822 4.400% | 249,600 (+1.18%) | Filing |
| 2020-07-31 4:05 pm Purchase | 2020-07-22 | 13D | Verona Pharma plc VRNA | Abingworth LLP | 21,064,222 5.100% | 21,064,222 (New Position) | Filing |